Medical Devices Investors & VC Firms in Sydney
13 firms in this list, with a median first check of $2.3M. 5 of them lead rounds. Generated from verified public data and updated continuously.
Blackbird Ventures
SydneyPre-Seed–Series B$149K – $60M
51 people
Artesian
SydneyPre-Seed–Growth$20M
41 people
OneVentures
SydneySeed–Late Stage$3.3M – $13.2M
40 people
Main Sequence Ventures
SydneyPre-Seed–Series B
25 people
Proto Axiom
SydneyPre-Seed–Seed
28 people
Crescent Capital Partners
SydneyGrowth–Late Stage$13.2M – $52.8M
24 people
Scalare Partners
SydneyPre-Seed–Series A
1 person
Stoic VC
SydneyPre-Seed–Seed$65K – $650K
6 people
Australian Technologies Competition
SydneySeries A–Growth
5 people
Remarkable Australia+ Accelerator
SydneyPre-Seed–Series A
UNSW
SydneyPre-Seed–Seed
Southern Cross Venture Partners
NarrabeenSeed–Growth$1.3M – $6.6M
4 people
Billfolda Ventures
UltimoPre-Seed–Seed
Frequently asked questions
- Who are the top medical devices investors & vc firms in sydney?
- Top medical devices investors & vc firms in sydney include Blackbird Ventures, Artesian, OneVentures, Main Sequence Ventures, Proto Axiom, Crescent Capital Partners, Scalare Partners, Stoic VC — 13 firms in total meet the criteria.
- What is the typical first check among medical devices investors & vc firms in sydney?
- The median first check among the 13 medical devices investors & vc firms in sydney tracked here is $2.3M.
- How many medical devices investors & vc firms in sydney lead rounds?
- 5 of the 13 medical devices investors & vc firms in sydney tracked here lead investment rounds.
Related lists
Investors & VC Firms in North America (12952)Investors & VC Firms in United States (11990)Investors & VC Firms in Europe (5859)Investors & VC Firms in Global (4787)AI & Machine Learning Investors & VC Firms (4629)Fintech Investors & VC Firms (4588)SaaS Investors & VC Firms (4239)Healthtech Investors & VC Firms (4227)Enterprise Software Investors & VC Firms (4136)Crypto & Web3 Investors & VC Firms (3986)
Data sourced from public filings and firms' own websites — see our methodology.









































